Hikma Pharmaceuticals Regulatory News (HIK)

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")

Period of return

From: 1 April 2023

To:

30 September 2023

Balance of unallotted securities under scheme(s) from previous return:

The Plans: 1,497,913 Ordinary Shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

The Plans: 0 Ordinary Shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2018 MIP: 438 Ordinary Shares of 10 pence

EIP: 378,765 Ordinary Shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

The Plans: 1,118,710 Ordinary Shares of 10 pence

Name of contact:

Hussein Arkhagha

Telephone number of contact:

+44(0)20 7399 2760